Evaluation of a systematic cardiovascular disease risk reduction strategy in primary healthcare: An exploratory study from Zhejiang, China

Journal of Public Health (United Kingdom)

Volumn 37, Issue 2, 2015, Pages 241-250

  Zou, Guanyang ^a   Wei, Xiaolin ^b   Gong, Weiwei ^c   Yin, Jia ^b   Walley, John ^a   Yu, Yunxian ^d   Zhang, Zhitong ^a   King, Rebecca ^a   Hu, Ruying ^c   Chen, Kun ^d   Yu, Min ^c  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c Zhejiang Provincial Centre for Disease Prevention and Control   (China)

^d ZHEJIANG UNIVERSITY   (China)

Author keywords

cardiovascular disease; China; primary healthcare; risk reduction

Indexed keywords

CARDIOVASCULAR AGENT;

ADULT; AGED; CARDIOVASCULAR DISEASES; CHINA; FEMALE; HEALTH CARE POLICY; HUMAN; LIFESTYLE; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PREVENTIVE HEALTH SERVICE; PRIMARY HEALTH CARE; PROCEDURES; PROGRAM EVALUATION; RISK FACTOR; RISK REDUCTION; RURAL POPULATION;

ADULT; AGED; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CHINA; FEMALE; HEALTH POLICY; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PREVENTIVE HEALTH SERVICES; PRIMARY HEALTH CARE; PROGRAM EVALUATION; RISK FACTORS; RISK REDUCTION BEHAVIOR; RURAL POPULATION;

EID: 84930686751     PISSN: 17413842     EISSN: 17413850     Source Type: Journal    
DOI: 10.1093/pubmed/fdu013     Document Type: Article

References (31)

1. National Center for Cardiovascular Diseases. Report on Cardiovascular Diseases in China, 2008-09. Beijing: Encyclopedia of China Publishing House, 2010.
2. World Bank. Toward a Healthy and Harmonious Life in China: Stemming the Rising Tide of non-Communicable Diseases. East Asia, Pacific Region: The World Bank Institutes, 2011.
3. Wei X, Zou G, Yin J et al. Characteristics of high risk people with cardiovascular disease in Chinese rural areas: clinical indictors, disease patterns and drug treatment. PLoS ONE 2013;8(1):e54169.
4. Yang W, Lu J, Weng J et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010;362(25):2425-26.
5. Wu Y, Huxley R, Li L et al. Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation 2008;118(25):2679-86.
6. Li H, Meng Q, Sun X et al. Prevalence, awareness, treatment, and control of hypertension in rural China: results from Shandong Province. J Hypertens 2010;28(3):432-8.
7. Wei X, Zou G, Gong Wet al. Cardiovascular disease risk reduction in rural China: A clustered randomized controlled trial in Zhejiang. Trials 2013;14(1):354.
8. Group TCSSSC. Salt substitution: A low-cost strategy for blood pressure control among rural Chinese. A randomized, controlled trial. J Hypertens 2007;25:2011-18. 10.1097/HJH.0b013e3282b9714b.
9. Li G, Zhang P, Wang J et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: A 20-year follow-up study. Lancet 2008;371(9626):1783-89.
10. Zhou B, Chen K, Yu Y et al. Individualized health intervention: The effect on behavior change and quality of life in the older rural Chinese population in Zhejiang province. Educ Gerontol 2010;36(10): 919-39.
11. NICE. Prevention of cardiovascular disease. NICE Public Health Guidance 25. Manchester: National Institute for Health and Clinical Excellence, 2010.
12. Law MR, Wald NJ, Morris JK et al. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ 2003;326(7404):1427.
13. Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 2003;326(7404): 1423.
14. Raju N, Sobieraj-Teague M, Hirsh J et al. Effect of aspirin on mortality in the primary prevention of cardiovascular disease. Am J Med 2011;124(7):621-29.
15. Seshasai S, Wijesuriya S, Sivakumaran R et al. Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials. Arch Intern Med 2012;172 (3):209-16.
16. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003;326(7404):1419.
17. Collaboration ATA. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009;337(9678): 1849-60.
18. Yusuf S, Pais P, Afzal R et al. Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): A phase II, double-blind, randomised trial. Lancet 2009;373(9672):1341-51.
19. Malekzadeh F, Marshall T, Pourshams A et al. A pilot double-blind randomised placebo-controlled trial of the effects of fixed-dose combination therapy ('polypill') on cardiovascular risk factors. Int J Clin Pract 2010;64(9):1220-7.
20. Gluckman TJ, Baranowski B, Ashen M et al. A practical and evidencebased approach to cardiovascular disease risk reduction. Arch Intern Med 2004;164(14):1490-500.
21. Wei X, Barnsley J, Zakus D et al. Evaluation of a diabetes management program in China demonstrated association of improved continuity of care with clinical outcomes. J Clin Epidemiol 2008;61(9): 932-39.
22. Lindström J, Ilanne-Parikka P, Peltonen M et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006;368 (9548):1673-79.
23. Kaczorowski J, Chambers LW, Dolovich L et al. Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP). BMJ 2011;342.
24. Liu M, Wu B, Wang WZ et al. Stroke in China: epidemiology, prevention, and management strategies. Lancet Neurol 2007;6(5): 456-64.
25. Brunton S. Improving medication adherence in chronic disease management. J Fam Pract 2011;60:(4 Suppl. S1-S8). http://www. jfponline.com/index.php?id=22143&tx-ttnews[tt-news]=165802.
26. Baker S, Priest P, Jackson R. Using thresholds based on risk of cardiovascular disease to target treatment for hypertension: modelling events averted and number treated. BMJ 2000;320:680-5.
27. Capewell S. Will screening individuals at high risk of cardiovascular events deliver large benefits? No. BMJ 2008;337.
28. Berra K. Challenges of changing lifestyle to reduce risk for cardiovascular disease. J Cardiovasc Nurs 2010;25(3):223-27.
29. Chang L, McAlister AL, Taylor WC et al. Behavioral change for blood pressure control among urban and rural adults in Taiwan. Health Promot Int 2003;18(3):219-28.
30. Kliner M, Knight A, Mamvura C et al. Using no-cost mobile phone reminders to improve attendance for HIV test results: A pilot study in rural Swaziland. Infect Dis Poverty 2013;2(1):12.
31. Wei X, Walley J, Liang X et al. Adapting a generic tuberculosis control operational guideline and scaling it up in China: A qualitative case study. BMC Public Health 2008;8(1):260.